Introduction to Lenalid (Lenalidomide)
Lenalid, manufactured by Natco Pharma Ltd., contains the active ingredient Lenalidomide and is available in a strength of 5mg. It is formulated as capsules for oral administration and is prescribed for the treatment of Multiple Myeloma.
Uses of Lenalid
Lenalid is specifically indicated for the treatment of Multiple Myeloma, a type of cancer affecting plasma cells in the bone marrow.
Benefits of Lenalid
This medication offers the benefit of potentially slowing disease progression, improving symptoms, and enhancing overall quality of life for patients with Multiple Myeloma.
Mechanism of Action of Lenalid
Lenalidomide, the active ingredient in Lenalid, works by modulating the immune system and interfering with the growth and survival of cancer cells in Multiple Myeloma. It also affects the microenvironment that supports tumor growth.